VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

EBMT 2021 | Patient-reported outcomes in HSCT

Patient-reported outcomes provide health information directly from the patient and may aid in hematopoietic stem-cell transplantation (HSCT) prognostication. In this video, Hélène Schoemans, MD, University of Leuven, Leuven, Belgium, discusses the use of patient-reported outcomes in HSCT. This interview took place during the 47th Annual Meeting of the European Group for Blood and Marrow Transplantation (EBMT) 2021.


Dr Hélène Schoemans, MD, has participated in advisory boards for Incyte, Janssen, and Novartis; has received speaker’s fees from Novartis, Incyte, Jazz Pharmaceuticals, the Belgian Hematological Society (BHS) and Takeda; has received travel grants from AbbVie, Celgene, CIBMTR, EBMT, Gilead and Incyte, has received research funding from Novartis and the BHS; and has volunteered for the BHS, the CIBMTR, EBMT, and EUPATI.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter